BEAM
Price
$15.16
Change
-$1.30 (-7.90%)
Updated
Apr 4, 04:29 PM (EDT)
Capitalization
1.64B
39 days until earnings call
FENC
Price
$5.16
Change
-$0.43 (-7.69%)
Updated
Apr 4, 04:20 PM (EDT)
Capitalization
162.59M
34 days until earnings call
Ad is loading...

BEAM vs FENC

Header iconBEAM vs FENC Comparison
Open Charts BEAM vs FENCBanner chart's image
Beam Therapeutics
Price$15.16
Change-$1.30 (-7.90%)
Volume$2.85K
Capitalization1.64B
Fennec Pharmaceuticals
Price$5.16
Change-$0.43 (-7.69%)
Volume$216
Capitalization162.59M
BEAM vs FENC Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. FENC commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and FENC is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (BEAM: $16.46 vs. FENC: $5.59)
Brand notoriety: BEAM and FENC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 171% vs. FENC: 73%
Market capitalization -- BEAM: $1.64B vs. FENC: $162.59M
BEAM [@Biotechnology] is valued at $1.64B. FENC’s [@Biotechnology] market capitalization is $162.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileFENC’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • FENC’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than FENC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while FENC’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • FENC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than FENC.

Price Growth

BEAM (@Biotechnology) experienced а -25.82% price change this week, while FENC (@Biotechnology) price change was -13.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.99%. For the same industry, the average monthly price growth was -16.86%, and the average quarterly price growth was -18.44%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

FENC is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-10.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.64B) has a higher market cap than FENC($163M). FENC YTD gains are higher at: -11.551 vs. BEAM (-33.629). FENC has higher annual earnings (EBITDA): 3.02M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. FENC (40.3M). FENC has less debt than BEAM: FENC (32.1M) vs BEAM (161M). BEAM has higher revenues than FENC: BEAM (63.5M) vs FENC (49.3M).
BEAMFENCBEAM / FENC
Capitalization1.64B163M1,008%
EBITDA-383.98M3.02M-12,719%
Gain YTD-33.629-11.551291%
P/E RatioN/A64.14-
Revenue63.5M49.3M129%
Total Cash851M40.3M2,112%
Total Debt161M32.1M502%
FUNDAMENTALS RATINGS
FENC: Fundamental Ratings
FENC
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMFENC
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 17 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGHCX23.34N/A
N/A
Hartford Healthcare C
ALCKX90.50N/A
N/A
AB Large Cap Growth K
VMIDX23.20N/A
N/A
VALIC Company I Mid Cap Index
WESCX20.59N/A
N/A
TETON Westwood SmallCap Equity AAA
BRSUX13.60N/A
N/A
MFS Blended Research Small Cap Eq R4